83697-75-0

Basic information

• Product Name: Benzamide, N-[[(4-ethoxyphenyl)amino]thioxomethyl]-
• CAS NO: 83697-75-0
• Molecular Formula: C16H16N2O2S
• Molecular Weight: 300.381
• Mol File: 83697-75-0.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Benzamide, N-[[(4-ethoxyphenyl)amino]thioxomethyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzamide, N-[[(4-ethoxyphenyl)amino]thioxomethyl]-(83697-75-0)
• EPA Substance Registry System: Benzamide, N-[[(4-ethoxyphenyl)amino]thioxomethyl]-(83697-75-0)

Safety Data

• Hazardous Substances Data: 83697-75-0(Hazardous Substances Data)

Upstream product

• 14002-51-8 4-biphenyl-carboxylic acid chloride 
• 98-88-4 benzoyl chloride 
• 156-43-4 4-Ethoxyaniline 
• 532-55-8 Benzoyl isothiocyanate 

Downstream Products

• 472981-27-4 2-(4-ethoxyphenylamino)-4-(2-methyl-imidazo[1,2-a]pyrimidin-3-yl)thiazole monohydrobromide 
• 131329-62-9 (N-(4-ethoxyphenyl)-N'-benzoylthiocarbamide)(H₂O)iron(III) succinimide 
• 131329-58-3 (N-(4-ethoxyphenyl)-N'-benzoylthiocarbamide)(H₂O)iron(III) phthalimide 
• 19345-31-4 N-[3-(4-ethoxy-phenyl)-4-methyl-3H-thiazol-2-ylidene]-benzamide 
• 19353-45-8 3-(4-ethoxy-phenyl)-4-phenyl-3H-thiazol-2-ylideneamine 
• 19353-44-7 3-(4-ethoxy-phenyl)-4-methyl-3H-thiazol-2-ylideneamine 
• 19345-28-9 2-benzoylimino-3-(4-ethoxy-phenyl)-4-phenyl-thiazolidin-4-ol 
• 19345-26-7 2-benzoylimino-3-(4-ethoxy-phenyl)-4-methyl-thiazolidin-4-ol 
• 880-29-5 1-(4-ethoxyphenyl)thiourea 

Relevant articles and documents

Antitubercular activities of the novel synthesized 1,2,4-triazole derivatives

1,2,4-Triazoles exert antimycobacterial activity by inhibiting the cell wall biosynthesis. In an attempt to developing lead compounds exhibiting antitubercular activities, a series of 1,2,4-triazole derivatives were synthesized by introducing various substitutes into a scaffold and the antitubercular activity was evaluated. The most potent compounds 3e and 8d showed their minimum inhibitory concentrations against Mycobacterium tuberculosis as 12.5 ??M. The results indicate that those compounds can be considered as leads for further development of new 1,2,4-triazole type candidates with high antitubercular activities.

HETEROCYCLIC COMPOUNDS AND USES AS ANTICANCER AGENTS

Novel compounds having a fused bicyclic heteroaromatic ring system substituted with a thiazole ring are disclosed. The compounds inhibit growth of a variety of types of cancer cells, and are thus useful for treating cancer. Efficacy of these compounds is demonstrated with a system for monitoring cell growth/migration, which shows they are potent inhibitors of growth and/or migration of cancer cells. In addition, compounds of the invention were shown to stop growth of tumors in vivo, and to reduce the size of tumors in vivo. Compositions comprising these compounds, and methods to use these compounds and compositions for treatment of cancers, are disclosed.

STUDIES ON THE MOESSBAUER SPECTRA OF SOME IRON(III) COMPLEXES WITH IMIDES AS PRIMARY AND SOME N-ARYL-N'-BENZOYLTHIOCARBAMIDES AS SECONDARY LIGANDS. EFFECT OF AMBIENT TEMPERATURE

Ten new mixed ligand complexes of iron(III) of the type , where Im = deprotonated phthalimide or succinimide and STC = some N-aryl-N'-benzoylthiocarbamide derivativesN-(2-chlorophenyl)-N'-benzoylthiocarbamide, N-(3-methoxyphenyl)-N'-be